The Journal of Immunology · 2008 · 58 citations · 29 references
Life SciencesBiochemistryImmunologyAutoimmunityCell SignalingSignal TransductionAutoimmune DiseasesImmune Cell SignalingImmune Gene RegulationImmune-mediated Inflammatory DiseasesInflammatory SignalingSystemic Lupus ErythematosusCd3 Complex SignalingDna-binding MotifsPromotersProtein DephosphorylationReceptor DephosphorylationSystemic Lupus Erythematosus Associations
T cells from patients with systemic lupus erythematosus are characterized by decreased expression of CD3zeta-chain and increased expression of FcRgamma-chain, which becomes part of the CD3 complex and contributes to aberrant signaling. Elf-1 enhances the expression of CD3zeta, whereas it suppresses the expression of FcRgamma gene and lupus T cells have decreased amounts of DNA-binding 98 kDa form of Elf-1. We show that the aberrantly increased PP2A in lupus T cells dephosphorylates Elf-1 at Thr-231. Dephosphorylation results in limited expression and binding of the 98 kDa Elf-1 form to the CD3zeta and FcRgamma promoters. Suppression of the expression of the PP2A leads to increased expression of CD3zeta and decreased expression of FcRgamma genes and correction of the early signaling response. Therefore, PP2A serves as a central determinant of abnormal T cell function in human lupus and may represent an appropriate treatment target.
29
The 1982 revised criteria for the classification of systemic lupus erythematosus
Eng M. Tan, Alan S. Cohen, James F. Fries et al. · Arthritis & Rheumatism · 1982 · 14.6K citations
Stamatis‐Nick C. Liossis, Xin Ding, Greg Dennis et al. · Journal of Clinical Investigation · 1998 · 336 citations · Full text